Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
19%
ALSO IN OZEM
OZEM
22
HOLDINGS
24%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.0% | 15.3% | 15.3% |
|
AMGEN INC | 3.9% | 3.5% | 3.5% |
|
PFIZER INC | 3.3% | 4.0% | 3.3% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.5% | 3.2% | 3.2% |
|
REGENERON PHARMACEUTICALS | 2.9% | 2.8% | 2.8% |
MEDX Overweight Relative to OZEM
|
ABBVIE INC | 8.5% |
 |
NOVARTIS AG-ADR | 6.8% |
|
IONIS PHARMACEUTICALS, INC. | 5.0% |
|
ALNYLAM PHARMACEUTICALS INC | 5.0% |
|
JOHNSON & JOHNSON | 4.9% |
|
BRISTOL-MYERS SQUIBB CO | 4.7% |
|
MERCK & CO. INC. | 3.7% |
 |
ALKERMES PLC | 3.4% |
|
BIOGEN IDEC INC | 2.9% |
|
CRISPR THERAPEUTICS AG | 2.9% |
MEDX Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -22.0% |
|
ROCHE HOLDING LTD | -4.2% |
|
ZEALAND PHARMA A/S | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
 |
ASCLETIS PHARMA, INC. | -3.6% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
 |
HANMI PHARM CO LTD | -3.4% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.3% |
 |
CHINA PHARMACEUTICAL GROUP | -2.0% |